Synapse - Steven Horwitz

Search Within

Steven M Horwitz

Results (666)

An exploratory analysis of brentuximab vedotin plus CHP (A plus CHP) in the frontline treatment of patients with CD30+ peripheral T-cell lymphomas (ECHELON-2): Impact of consolidative stem cell transplant

Meeting Abstract

Savage, K. J.; Horwitz, S. M.; Advani, R. H.; Christensen, J. H.; Domingo-Domenech, E.; Rossi, G.; Morschhauser, F.; Alpdogan, O.; Suh, C.; Tobinai, K.; more...
Blood (2019)

Fulltext@MSK | Save

A phase 2 study of the dual SYK/JAK inhibitor cerdulatinib demonstrates good tolerability and clinical response in relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Meeting Abstract

Horwitz, S. M.; Feldman, T. A.; Hess, B. T.; Khodadoust, M. S.; Kim, Y. H.; Munoz, J.; Patel, M. R.; Phillips, T. J.; Smith, S. D.; Smith, S. M.; more...
Blood (2019)

Fulltext@MSK | Save

Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution

Meeting Abstract

Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
Blood (2019)

Fulltext@MSK | Save

Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution

Meeting Abstract

Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
Blood (2019)

Fulltext@MSK | Save

Brentuximab vedotin (BV) versus physician's choice (PC) of methotrexate or bexarotene in adult patients with previously treated CD30-positive cutaneous T-cell lymphoma (CTCL; mycosis fungoides [MF] or primary cutaneous anaplastic large cell lymphoma [pcALCL]): Final time to next therapy (TTNT) results from the phase 3 ALCANZA study

Meeting Abstract

Scarisbrick, J.; Horwitz, S. M.; Prince, H. M.; Whittaker, S.; Duvic, M.; Kim, Y. H.; Quaglino, P.; Zinzani, P. L.; Bechter, O.; Eradat, H.; more...
European Journal of Cancer (2019)

Fulltext@MSK | Save

Outcomes and prognostic factors in African American/Black patients with mycosis fungoides and Sézary syndrome

Meeting Abstract

Geller, S.; Lebowitz, E.; Pulitzer, M. P.; Horwitz, S. M.; Moskowitz, A. J.; Dusza, S.; Myskowski, P. L.
European Journal of Cancer (2019)

Fulltext@MSK | Save

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Journal Article

Kurzrock, R.; Gurski, L. A.; Carlson, R. W.; Ettinger, D. S.; Horwitz, S. M.; Kumar, S. K.; Million, L.; von Mehren, M.; Benson, A. B. 3rd
Annals of Oncology (2019)

Fulltext@MSK | Save

TFH lymphomas: The times they aza-changin'?

Editorial

Weinstock, D. M.; Horwitz, S. M.
Blood (2019)

Fulltext@MSK | Save

Response to brentuximab vedotin by CD30 expression: Results from five trials in PTCL, CTCL, and B-cell lymphomas

Meeting Abstract

Jagadeesh, D.; Horwitz, S. M.; Bartlett, N. L.; Advani, R. H.; Jacobsen, E. D.; Duvic, M.; Gautam, A.; Rao, S.; Onsum, M.; Fanale, M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants

Meeting Abstract

Ghione, P.; Cordeiro, P. G.; Ni, A.; Hu, Q. Y.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save